Trials / Completed
CompletedNCT02536105
PK/PD Pediatric ADHD Classroom Study
Pharmacokinetic Pharmacodynamic Studies of Methylphenidate Extended Release Products in Pediatric Attention Deficit Hyperactivity Disorder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the association between blood drug levels and the corresponding scores of commonly used behavioral instruments based upon data collected following administration of three different methylphenidate hydrochloride extended-release drug products in children with ADHD.
Detailed description
This is a randomized, double-blind, 4-treatment and 4-period crossover study conducted in a school laboratory environment to evaluate the hour-by-hour behavioral instrument scores and hour-by-hour PK of 3 different extended-release MPH formulations as well as placebo in children with ADHD. The complete study consists of three periods: Screening, Dose Titration and Double-Blind Crossover in a Laboratory Classroom. The double-blind phase will consist of four periods (or four weeks): each week will consist of blinded administration with one of the three active methylphenidate hydrochloride treatments or placebo from Sunday through Saturday. On the last day of each period (Saturday), study participants will be evaluated in a laboratory classroom setting. On Saturdays, the blinded doses of each study drug will be administered at the school site by study staff on the morning of the test laboratory classroom day. On the other days, the medication will be taken in the morning at home.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylphenidate HCl ER tablets 1 | |
| DRUG | Placebo | |
| DRUG | Methylphenidate HCl ER tablets 2 | |
| DRUG | Methylphenidate HCl ER for suspension |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2018-07-01
- Completion
- 2018-07-01
- First posted
- 2015-08-31
- Last updated
- 2019-12-10
- Results posted
- 2019-12-10
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02536105. Inclusion in this directory is not an endorsement.